Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Use of clonidine in children with autism spectrum disorders.

Ming X, Gordon E, Kang N, Wagner GC.

Brain Dev. 2008 Aug;30(7):454-60. doi: 10.1016/j.braindev.2007.12.007. Epub 2008 Feb 15.

PMID:
18280681
2.

Clonidine treatment of hyperactive and impulsive children with autistic disorder.

Jaselskis CA, Cook EH Jr, Fletcher KE, Leventhal BL.

J Clin Psychopharmacol. 1992 Oct;12(5):322-7.

PMID:
1479049
3.
4.

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.

Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD.

J Clin Psychiatry. 1992 Mar;53(3):77-82.

PMID:
1548248
5.

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.

Connor DF, Fletcher KE, Swanson JM.

J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12):1551-9.

PMID:
10596256
6.

Guanfacine in children with autism and/or intellectual disabilities.

Handen BL, Sahl R, Hardan AY.

J Dev Behav Pediatr. 2008 Aug;29(4):303-8. doi: 10.1097/DBP.0b013e3181739b9d.

PMID:
18552703
7.

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.

Prince JB, Wilens TE, Biederman J, Spencer TJ, Wozniak JR.

J Am Acad Child Adolesc Psychiatry. 1996 May;35(5):599-605.

PMID:
8935206
8.

Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.

Ghanizadeh A.

J Clin Psychopharmacol. 2008 Dec;28(6):725-6. doi: 10.1097/JCP.0b013e31818ce741. No abstract available.

PMID:
19011458
9.

Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.

Blumer JL, Findling RL, Shih WJ, Soubrane C, Reed MD.

Pediatrics. 2009 May;123(5):e770-6. doi: 10.1542/peds.2008-2945.

PMID:
19403468
10.

Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD.

Nair V, Mahadevan S.

J Trop Pediatr. 2009 Apr;55(2):116-21. doi: 10.1093/tropej/fmn117. Epub 2009 Feb 8.

PMID:
19203986
11.

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.

Int Clin Psychopharmacol. 2006 Nov;21(6):363-7.

PMID:
17012983
12.

Lofexidine in hyperactive and impulsive children with autistic disorder.

Niederhofer H, Staffen W, Mair A.

J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1396-7. No abstract available.

PMID:
12447025
13.

An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder.

Hunt RD, Arnsten AF, Asbell MD.

J Am Acad Child Adolesc Psychiatry. 1995 Jan;34(1):50-4.

PMID:
7860456
14.

Role of risperidone in children with autism spectrum disorder.

Chavez B, Chavez-Brown M, Rey JA.

Ann Pharmacother. 2006 May;40(5):909-16. Epub 2006 Mar 7. Review.

PMID:
16684811
15.

Decreased use of clonidine following treatment with atomoxetine in children with ADHD.

Johnston JA, Ye W, Van Brunt DL, Pohl G, Sumner CR.

J Clin Psychopharmacol. 2006 Aug;26(4):389-95.

PMID:
16855457
16.

Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation.

Agarwal V, Sitholey P, Kumar S, Prasad M.

Ment Retard. 2001 Aug;39(4):259-67.

PMID:
11448249
17.
18.

Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.

Valicenti-McDermott MR, Demb H.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):549-60.

PMID:
17069544
19.

Melatonin for insomnia in children with autism spectrum disorders.

Andersen IM, Kaczmarska J, McGrew SG, Malow BA.

J Child Neurol. 2008 May;23(5):482-5. doi: 10.1177/0883073807309783. Epub 2008 Jan 8.

PMID:
18182647
20.

Sleep disturbances in children with psychiatric disorders.

Ivanenko A, Johnson K.

Semin Pediatr Neurol. 2008 Jun;15(2):70-8. doi: 10.1016/j.spen.2008.03.008. Review.

PMID:
18555193

Supplemental Content

Support Center